News

UBS Forecasts Limited Growth for Global Shares by 2025

UBS Forecasts Limited Growth for Global Shares by 2025

UBS Forecasts Limited Growth for Global Shares by 2025

Global equity markets are often a topic of discussion among investors and analysts. Recently, UBS has provided a conservative outlook for the MSCI All-Country World Equity Index, anticipating only a modest upside by the end of 2025. The investment bank has set a price target of 900 for this index, indicating a mere 6% increase from current levels.

Key Factors Behind the UBS Outlook

UBS's forecast stems from a range of economic indicators and underlying factors influencing market dynamics. These elements demonstrate a cautious approach toward global equities and highlight areas that could either support or hinder growth.

Understanding Tactical Indicators

One of the primary factors contributing to their outlook is the performance of tactical indicators. The UBS risk appetite indicator reflects a lukewarm sentiment regarding risk assets, which are closely aligned with current economic momentum. For example, recent estimates from U.S. GDP growth are hovering around 1%, indicating a relatively subdued economic environment.

Interest Rate Implications

Furthermore, UBS emphasizes the historical pattern in which equities perform well following interest rate cuts by the U.S. Federal Reserve, especially when such actions do not lead to a hard landing. While they do not foresee such a scenario occurring in the U.S. in the near future, they maintain a hopeful outlook for growth in 2025 and 2026. Past performance has shown that equities typically gain around 20% during an eight-month window post-rate cuts. UBS anticipates a further increase of approximately 13%, suggesting a cautiously optimistic road ahead.

Generative AI's Impact on Productivity

UBS also brings attention to the role of generative AI (Gen AI) in transforming productivity levels across various sectors. The expectations surrounding Gen AI could lead to a boost in the U.S. equity risk premium (ERP) to around 4.9%. The anticipated productivity gains may support a considerable upside potential of approximately 10% for equities, with defensive sectors like healthcare, utilities, and technology standing to benefit the most.

Marginal Growth Projections

Another noteworthy point made by UBS relates to wage growth and its effects on margins. For 2025, they predict that wage growth in the U.S. will slow to roughly 3%. This scenario may ease the pressure on margins for numerous corporations, particularly those outside the largest U.S. firms. Moreover, UBS continues to forecast earnings growth significantly below consensus estimates, projecting 5% as opposed to a more common 13% growth forecast.

The Importance of the Credit Environment

The relationship between credit and equities is also pivotal in UBS's analysis. They refer to these two assets as being “tied at the hip,” indicating that substantial changes in equity performance often predate shifts in credit spreads. At present, credit spreads imply a lower volatility index (VIX), and defaults are occurring at a rate markedly lower than what high-yield spreads might suggest. Moreover, the positive balance between credit upgrades and downgrades adds to the complexity of the current financial landscape.

Balancing Risks and Opportunities

While UBS maintains a primary case describing a 6% upside potential, the firm also acknowledges a more optimistic scenario, estimating a 25% occurrence of a market bubble. In this situation, equities could rise by over 20% if monetary conditions in major economies, particularly the U.S. and China, become more favorable. Conversely, they also recognize a 25% chance of a market downturn of about 10%, influenced by recession risks in the U.S. and challenges posed by economic trends in China.

Conclusion

In summary, as global investors navigate the complexities of market dynamics influenced by economic indicators, interest rate trends, and technological advancements, UBS's projections serve as a prompt for a measured approach towards equity investments through 2025. The prudent discourse around achievable returns reinforces the notion that markets remain unpredictable, and embracing a well-researched perspective is crucial for success.

Frequently Asked Questions

What is the price target set by UBS for the MSCI All-Country World Equity Index?

UBS has set a price target of 900 for the MSCI All-Country World Equity Index by the end of 2025.

What factors contribute to UBS's cautious outlook?

Factors include tactical indicators, the impact of interest rate decisions, and expectations surrounding generative AI.

How does wage growth affect corporate margins?

Slower wage growth may alleviate margin pressures for many businesses, especially smaller firms.

What is the projected upside potential for equities according to UBS?

UBS anticipates a potential upside of 6%, but also acknowledges scenarios where equities might rise by over 20% or decline by 10%.

Why is the credit environment critical for equity performance?

The credit environment is essential as shifts in credit spreads often foreshadow changes in equity performance, influencing investment strategies.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 310

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 607

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 386

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 513

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 731

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
Cardiovalve's Three-Year Data Clears a Crucial EU Hurdle

Updated Category News Views 98

A failing tricuspid valve is not a spreadsheet problem, and that matters before anybody gets carried away with a glossy conference presentation. Venus Medtech's Cardiovalve unit has reported results from TARGET in a population that was old, sick and largely out of good surgical options. That is precisely where a less invasive replacement therapy has to prove it can do...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 385

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 518

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
FASTEN Data Offers an Early Look at Ladera Closure

Updated Category News Views 137

Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 332

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
icles